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Available online 19 March 2016Mef2c Anterior Heart Field (AHF) enhancer is activated during embryonic heart development and it is expressed in
multipotent cardiovascular progenitors (CVP) giving rise to endothelial and myocardial components of the outﬂow
tract, right ventricle and ventricular septum. Here we have generated iPSC from transgenic Mef2c-AHF-Cre x
Ai6(RCLZsGreen) mice. These iPSC will provide a novel tool to investigate the AHF-CVP and their cell progeny.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Tail-tip ﬁbroblasts (TTF) and cardiac ﬁbroblasts (CF) derived
from Mef2c-AHF-Cre (Verzi et al., 2005) x Ai6(RCLZsGreen)
(Madisen et al., 2010) mice were transduced with Oct4, Sox2,
Klf4 and c-Myc (OSKM) with the pMXs retrovirus vectors. Mouse
ES-like colonies appeared 15–20 days after transduction and
were picked and seeded on irradiated mouse embryonic ﬁbro-
blasts (ɣMEFs) and maintained with LIF. Established iPSC, AHF-
iPSC, derived from TTF (AHFiPS7) and CF (AHFiPS19) encoded
the expected genomic insertions (Fig. 1a). The karyotypes of
AHF-iPSC were normal (Fig. 1b) and the transgenes were silenced
in established AHF-iPSC lines as shown by qRT-PCR (Fig. 1c). En-
dogenous pluripotency-associated markers such Oct4, Sox2,
Nanog and Zfp42 were expressed in AHF-iPSC, analyzed by qRT-
PCR (Fig. 1d), and Nanog (Fig. 1e) and alkaline phosphatase (AP,
Fig. 1f) expression was veriﬁed by cell staining. To demonstrate
the capacity of AHF-iPSC lines to differentiate into the three
germ layers we performed in vivo teratoma and in vitro embryoid
body (EB) differentiation assays. Teratomas contained tissues de-
rived from the three germ layers (Fig. 2a). We collected RNA
from undifferentiated AHF-iPSC and from EB on day 7 and 14 of
differentiation. Increased expression of Cxcl12/Mash1 (ecto-
derm), Acta2/Myh6 (mesoderm) and Hnf4a/Afp (endoderm),
(Fig. 2b) was observed. Mef2c and ZsGreen were not detected in
undifferentiated AHF-iPSC, however, the expression of Mef2c
and ZsGreen was conﬁrmed by qRT-PCR on day 7 and 14 of differ-
entiation (Fig. 2b), and ZsGreen was observed under ﬂuorescence
microscopy (Fig. 2c).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of AHFiPS7 and AHFiPS19 cell lines. a) AHFiPS7 and AHFiPS19 encode the expected knock in sequences in ROSA and AHF loci. Samples from wild-
type C57BL/6, and Ai6 andMef2c-AHF-Cre mice were used as negative and positive controls, respectively. b) Karyotype analysis of AHFiPS7 and AHFiPS19. Normal karyotypes
of 40, XY. c) Transgene (Tg) silencing of Oct4, Sox2, Klf4 and c-Myc in the established AHF-iPSC lines was veriﬁed by qRT-PCR after passage 9. Infected ﬁbroblast samples were
used as positive control of the Tg expression. d) Gene expression analysis by qRT-PCR of the endogenous pluripotency-associated markers Oct4, Sox2, Nanog and Zfp42. Black
bars: CCE; white bars: AHFiPS7; grey bars: AHFiPS19. e) Immunostaining against Nanog in AHFiPS7, AHFiPS19. Nuclei: Hoescht staining. f) Alkaline phosphatase enzymatic
activity of AHFiPS7 and AHFiPS19.
Fig. 2. Differentiation potential of AHFiPS7 and AHFiPS19 cell lines. a) In vivo differentiation: teratoma formation assay. The pictures show H&E staining with representative tissues
from the three germ layers. Neural rosettes (left), cartilage tissue and muscle (middle), and endodermal epitheliums (right). b) In vitro differentiation: EB differentiation assay. Gene
expression analysis by qRT-PCR of ZsGreen and Mef2c, and markers of ectoderm (Cxcl12 and Mash1), mesoderm (Acta2 and Myh6), and endoderm (Hnf4a and Afp). Solid lines:
AHFiPS7; dashed lines: AHFiPS19. c) ZsGreen expression was analyzed by ﬂuorescence microscopy in undifferentiated AHF-iPSC and in EB on day 7 and 14 of differentiation. Scale bar,
100 μm.
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Table 1
Primer sequences used in this study.
Gene Forward Reverse
GAPDH CCACTCACGGCAAATTCA AGTAGACTCCACGACATACTC
Endo Oct4 TAGGTGAGCCGTCTTTCCAC GGTGAGAAGGCGAAGTCTGA
Endo Sox2 AAGGGTTCTTGCTGGGTTTT AGACCACGAAAACGGTCTTG
Nanog CGCCATCACACTGACATGAG GAGGCAGGTCTTCAGAGGAA
Zfp42 CCCTCGACAGACTGACCCTAA TCGGGGCTAATCTCACTTTCAT
Tg pMXmKlf4 ACGCAGTGTCTTCTCCCTTC GTGTGGTGGTACGGGAAATC
Tg pMXmSox2 GTGTGGTGGTACGGGAAATC TTCAGCTCCGTCTCCATCAT
Tg pMXmOct4 TAGCCAGGTTCGAGAATCCA GTGTGGTGGTACGGGAAATC
Tg pMXm-c-Myc CGCAGATGAAATAGGGCTGT GTGTGGTGGTACGGGAAATC
ZsGreen TTCTACGGCGTGAACTTCCC CTCACGTCGCCCTTCAAGAT
Mef2c ATCCCGATGCAGACGATTCAG AACAGCACACAATCTTTGCCT
Acta2 GTCCCAGACATCAGGGAGTAA TCGGATACTTCAGCGTCAGGA
Myh6 ATGTTAAGGCCAAGGTCGTG CACCTGGTCCTCCTTTATGG
Afp CTTCCCTCATCCTCCTGCTAC ACAAACTGGGTAAAGGTGAT
GG
Hnf4a CCAAGAGGTCCATGGTGTTT TGAGGCAGGCATATTCATTG
Cxcl12 CTTCCTCCCAGAAGTCAGTCAT
CC
ACACAACACTGAACCCATCG
CTG
Mash1 ACTTGAACTCTATGGCGGGTT CCAGTTGGTAAAGTCCAGCAG
AHF-Cre TGCCACGACCAAGTGACAGC CCAGGTTACGGATATAGTTC
ATG
ROSA26-WT AAGGGAGCTGCAGTGGAGTA CCGAAAATCTGTGGGAAGTC
ROSA26-KI GGCATTAAAGCAGCGTATCC AACCAGAAGTGGCACCTGAC
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Cell isolation and culture
All procedures were in compliance with institutional and European
Union guidelines for animal care andwelfare under speciﬁc experimen-
tal procedures approved by the Ethics Committee of the University of
Navarra. Mef2c-AHF-Cre mouse strain was kindly provided by Dr.
Brian L. Black (USCF, CA). Mef2c-AHF-Cre mice were crossed with
Ai6(RCLZsGreen) mice (Ai6 mice, The Jackson Laboratory). TTF and CF
were isolated from 8-week-old Mef2c-AHF-Cre x Ai6 mice. Tail-tip tis-
sue and heart tissue was minced and treated with 2 mg/ml collagenase
type I (Gibco) and 1 mg/ml liberase (Roche), respectively, ﬁltered
through a 40 μm mesh (Falcon), and seeded on culture plates pre-
coated with 0.1% gelatin (Millipore) in DMEM supplemented with 10%
fetal bovine serum (FBS, Gibco), 2 mM Glutamax (Gibco), 0.1 mM
MEM non-essential amino acids (NEAA, Lonza), 100 UI/ml penicillin/
streptomycin (P/S, Lonza), and 1 ng/mL of bFGF (Peprotech). Fibroblasts
were expanded for three passages before infection.
Transfection, iPSC generation and culture
TTF and CF were infected with ecotropic MMLV retrovirus encoding
themouse reprogramming factors Oct4, Sox2, Klf4 and c-Myc (Addgene
plasmids 13,366;13,367;13,370;13,375) as described (Takahashi and
Yamanaka, 2006). 3 days after infection, 8.3 x 103 cells per well of a 6-
well plate (Corning Costar) were seeded onto irradiated mouse embry-
onic ﬁbroblasts (ɣMEFs). The following day the medium was replaced
with the iPSC medium: DMEM, 15% Knock-out serum replacement, 5%
FBS, 0.1 mM 2-mercaptoethanol, 2 mM Glutamax (all from Gibco),
100 UI/ml P/S (Lonza), 0.1 mM NEAA and 103 U/ml LIF (Millipore).
The media was changed every other day. Three weeks after infection
iPSC colonies were picked and maintained on ɣMEFs in iPSC medium.
Knock in veriﬁcation in iPSC
We PCR ampliﬁed the genomic DNA (gDNA) sequences used for the
genotyping of the Mef2c-AHF-Cre and Ai6 mice with the primers listed
in Table 1. gDNA was isolated with NucleoSpin® Tissue (Macherey
Nagel) and 50 ng of gDNA were used per reaction. gDNA from a tissue
sample of homozygous Mef2c-AHF-Cre and homozygous Ai6 mice wasused as positive control and gDNA of a wild-type C57BL/6 mice was
used as negative control.
Karyotyping
iPSCwere grownona T25 ﬂask pre-coatedwith 0.1% gelatin. The day
of culture harvest, 20 μl of colcemid (10 μg/ml) was added to themedia
which was 70–80% conﬂuent. The culture was re-incubated for 1 h at
37 °C. The cells were washed with phosphate buffered saline (PBS)
and 2 ml of pre-warmed hypotonic solution (potassium chloride) was
added drop by drop and incubated for 30 min at 37 °C, followed by
the ﬁxation in Carnoy solution. The samples were further processed
and analyzed by the Genetics Service at Policlinica Gipuzkoa.
Alkaline phosphatase staining and immunostaining
iPSC were ﬁxed with 4% paraformaldehyde (PFA) for 2 min, washed
with PBS and stained with Alkaline Phosphatase (AP) Blue Membrane
Substrate Solution following the manufacturer's instructions (Sigma).
For intracellular staining, cells were ﬁxed in 4% PFA for 15 min, and
blocked and permeabilized in PBS containing 10% FBS, 1% BSA and
0.1% Triton X-100 for 30min. Cells were incubated with NANOG prima-
ry antibody (1:100, Abcam) in blocking solution overnight at 4 °C,
washed and incubated with Alexa 488 secondary antibody (1:500, Life
Technologies) for 1 h at room temperature. The cells were washed
and stained with Hoechst (10 μg/mL) for 20 min.
Teratoma formation assay
All animal procedureswere performed in accordancewith the ethical
guidelines from Animal Care and Use Committee of University of Navar-
ra. One million iPSC in matrigel:PBS (1:1) were injected subcutaneously
into the hind-leg of immunodeﬁcientmice (Rag2−/−γc−/−). Teratomas
were excised 3 weeks post-injection, ﬁxed overnight in 10% formalin,
embedded in parafﬁn, sectioned and stained with hematoxylin and
eosin (H&E) by the Imaging Core at CIMA. Histological evaluation was
performed using a Leica DM IL LED microscope and LAS EZ software.
EB differentiation assay
For EB formation, iPSCwere grown on a 6-well plate pre-coatedwith
0.1% gelatin. iPSC were dissociated with TrypLE (Gibco) for 3–5 min.
After centrifuging, cell pellets were resuspended in iPSC medium with-
out LIF, ﬁltered through a 40 μm cell strainer (Falcon) and plated in
AggreWell™400 plates (STEMCELL Technologies) and incubated for
24 h. EB were collected, resuspended in basic differentiation media
and cultured in 10-cm petri dish. Basic differentiation media consist of
DMEM supplemented with 10% FBS, 2 mM Glutamax, 100 UI/ml P/S,
0.1 mM NEAA, 1-thioglycerol (0.4 mM, Sigma). Ascorbic acid (50 μg/
ml; Sigma) and transferrin (90 μg/ml; Roche Life Science) were added
from EB day 1 to day 5. EB were collected and RNA was isolated at day
7 and 14 of differentiation for qRT-PCR analyses.
Quantitative real-time PCR (qRT-PCR)
RNA was isolated using TRIzol reagent (Life Technologies) or
Maxwell® 16 LEV simplyRNA Cells Kit (Promega), and ﬁrst-strand
cDNA was synthesized using PrimeScript™ RT reagent Kit (Takara) ac-
cording to the manufacturer's recommended protocol. The cDNA was
diluted with RNase-free water at a concentration of 10 ng/ml. Primers,
listed in Table 1, were designed using Primer3 input software or
Primerbank resource. qRT-PCR was performed on a 7500 Real-Time
PCR System (Applied Biosystems) with SYBR Green Master Mix
(Applied Biosystems).Expression levels of pluripotency-associated
markers were compared to CCE mouse embryonic stem cells (ATCC,
SCRC-1023™). Silencing of the transgene expression was analysed
621J. Linares et al. / Stem Cell Research 16 (2016) 617–621using non-infected ﬁbroblast samples as reference. Expression levels of
differentiation markers were compared to undifferentiated AHF-iPSC.
All the qPCR reactions were normalized against GAPDH and error bars
indicate ± s.d. of triplicates.
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